Millie
your market intelligence analyst
Search Results
169 results
Your search is now limited to «Cystic Fibrosis» expert search.
FeedNavigator (EU) 08/20/2019 11:22
Cystic fibrosis related diabetes (CFRD) screening rates of clinics are significantly associated with time to diagnosis.
More from FeedNavigator (EU):
The third study involved 39 patients over 6 years of age with cystic fibrosis due to several mutations other than G551D.
More from European Medicines Agency - EMEA (EU):
ENDPOINTS 08/20/2019 09:46
Vertex has clinched a priority review for the all-important cystic fibrosis triple that will blaze the trail for treating a large group of patients unhelped by its current drugs.
More from ENDPOINTS:
ClinicalTrials.gov 08/16/2019 07:07
Condition : Cystic Fibrosis Interventions : Drug: BI 1265162; Drug: Placebo Sponsor : Boehringer Ingelheim Not yet recruiting.
More from ClinicalTrials.gov:
Risk of cystic fibrosis-related diabetes may be tied to high levels of the liver enzyme alanine aminotransferase in the blood, especially in male patients according to a Plos One study.
More from RT: For Decision Makers in Respiratory Care:
pharmaphorum 08/15/2019 07:52
David Ramsden, chief executive at the Cystic Fibrosis Trust, said: “The SMC’s advice will come as a shock to people with cystic fibrosis and their families in Scotland.
More from pharmaphorum:
European Respiratory Journal 08/14/2019 19:05
The major cause of lung damage in cystic fibrosis (CF) is infection with bacterial pathogens, the most prevalent of which is Pseudomonas aeruginosa (Pa), chronically infecting ~60% patients by adolescence/adulthood (www.cysticfibrosis.org.uk/news/registry-report-2017).
More from European Respiratory Journal:
STAT 08/13/2019 09:46
Vertex, known for cystic fibrosis drugs, sets its sights on taming pain.
More from STAT:
PMLiVE 08/13/2019 07:19
The Scottish Medicines Consortium (SMC) has not recommended Vertex’s cystic fibrosis drugs Orkambi (lumacaftor/ivacaftor) and Symkevi (tezacaftor/ivacaftor) for routine NHS use in Scotland.
More from PMLiVE:
Evidence of limited quality from one retrospective study analyzing registry data suggest that the use of inhaled corticosteroids in children (six to 12 years old) with cystic fibrosis may decrease the yearly rate of decline in lung function.
More from U.S. Department of Health & Human Services - HHS.gov (HHS):
Cystic Fibrosis Trust chief executive David Ramsden said: 'The SMC's advice will come as a shock to people with cystic fibrosis and their families in Scotland.
More from Mail on Sunday (United Kingdom):
inews.co.uk (UK) 08/12/2019 13:15
People with cystic fibrosis in Scotland will continue to be denied potentially life-extending drugs after they were rejected for use by the NHS, prompting an outpouring of dismay and anger.
More from inews.co.uk (UK):

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications